Investigational Drug Reduces Brain Lesions in Highly Active MS ...Middle East

Medscape - News
Tolebrutinib, a Bruton's tyrosine kinase inhibitor, is associated with a 93% reduction in new gadolinium-enhancing lesions in patients with highly active relapsing-remitting MS. Medscape Medical News

Hence then, the article about investigational drug reduces brain lesions in highly active ms was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Investigational Drug Reduces Brain Lesions in Highly Active MS )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 8 minute